Athene Holding Ltd. current report, 18 June 2020

Athene Holding Ltd. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Athene Holding Ltd. on June 18, 2020. The filing details a definitive material agreement entered into on the same date by Athene Life Re Ltd. (ALRe), a wholly owned subsidiary of Athene, with Jackson National Life Insurance Company (JNL).

Key Financial Metrics and Transaction Details

  • Reinsurance Scope: ALRe reinsured a 100% quota share of a block of fixed annuity and fixed indexed annuity liabilities from JNL.
  • Ceded Reserves: Approximately $26.7 billion in statutory reserves were ceded as of June 1, 2020.
  • Ceding Commission: JNL received a ceding commission of approximately $1.25 billion.
  • Capital Deployment: Approximately $1.2 billion of capital is expected to be deployed over the next 12 to 18 months to support the transaction and redeploy the investment portfolio.
  • Funding Structure: Capital deployment is split between third-party investors in Athene Co-Invest Reinsurance Affiliate 1A Ltd. (ACRA) at 63% and Athene on a stand-alone basis at 37%.
  • Equity Investment: ALRe agreed to acquire 87 Class A and 13 Class B shares of Brooke (Holdco 1), Inc. (an indirect parent of JNL) for an aggregate price of $500 million.
  • Ownership Stake: The equity acquisition represents an 11.1% equity interest in Brooke HoldCo and 9.9% of its aggregate voting power.

Material Changes and Transaction Mechanics

The transaction involves a funds withheld coinsurance basis where ALRe provides collateral to JNL through assets withheld, trust accounts, and letters of credit. JNL will continue to service and administer the annuities for a fee. The agreement includes customary representations, warranties, indemnification provisions, and limited recapture/termination rights triggered by capital levels or tax events.

Outlook, Risks, and Contingencies

The closing of the $500 million equity investment is contingent upon customary closing conditions, specifically the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The filing does not provide specific forward-looking financial guidance regarding revenue or profit margins for the reporting period, as this is a transactional filing rather than a periodic financial report.

Key Facts for Investor Verification

  • Confirmation of the Hart-Scott-Rodino waiting period expiration to validate the closing of the $500 million equity stake in Brooke HoldCo.
  • Verification of the $1.2 billion capital deployment timeline and the specific funding sources from third-party investors in ACRA.
  • Assessment of the impact of the $26.7 billion ceded reserves on Athene's balance sheet and capital adequacy ratios.
  • Review of the service fee structure JNL will charge for administering the reinsured business.